For people 1 year of age and older with SHORT BOWEL SYNDROME (SBS) who are dependent on parenteral support (PS)
less parenteral support.*
more time doing what you love.
Learn about Gattex
In a 6-month study of 86 adults, 63% of adults treated with GATTEX reduced their weekly volume of PS by 20% or more (vs 30% with placebo). 54% of adults treated with GATTEX achieved at least 1 day off of PS per week (vs 23% with placebo).
Betsy,
gattex patient
In clinical studies, GATTEX was proven to help people with short bowel syndrome (SBS) on parenteral support (PS)
Volume
GATTEX reduced the weekly volume of parenteral support (PS).
Time
People treated with GATTEX achieved more time off of parenteral support (PS).
Freedom
Over time, some people achieved complete freedom from parenteral support (PS) with GATTEX.
In a 6-month study, 27 out of 43 adults treated with GATTEX reduced weekly PS volume by 20% or more vs 13 out of 43 on placebo, and 21 out of 39 achieved at least 1 day off PS per week vs 9 out of 39 on placebo. After 30 months of treatment, 10 out of 30 adults no longer needed PS. In a 6-month study, 18 out of 26 children treated with GATTEX reduced weekly PS volume by 20% or more, 10 out of 26 achieved a reduction of at least 1 day off PS per week, and 3 out of 26 no longer needed PS.
Less time on PS could mean more time for:
Work
Hobbies
School
Social
interaction
Sleep and
rest
Examples of how some patients may spend their time with reduced PS requirements are for illustrative purposes only. Be sure to discuss your medical circumstances and activities with your doctor.
About Short Bowel Syndrome (SBS)
SBS is a serious and chronic malabsorption disorder.
Learn About SBSConsidering GATTEX?
Download our helpful Conversation Guide or see what goes into getting started.
Getting startedProduct Support & Resources
Connect with others, download resources, and learn about our patient support program.
Access resourcesgattex patient
Stay informed and connected
Sign up to receive ongoing updates and communications about upcoming events, treatment information, education, resources, and market research opportunities.
Please see our online privacy notice for information about our practices regarding collection, use, and disclosure of information that you may provide us.